News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
109,935 Results
Type
Article (5749)
Company Profile (7)
Press Release (104179)
Section
Business (32738)
Career Advice (96)
Deals (6221)
Drug Delivery (5)
Drug Development (12472)
Employer Resources (9)
FDA (2352)
Job Trends (1520)
News (55224)
Policy (5105)
Tag
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (1)
2024 Genetown Digital (1)
Academia (357)
Adcomms (1)
Allergies (7)
Alliances (11853)
ALS (18)
Alzheimer's disease (172)
Antibody-drug conjugate (ADC) (16)
Approvals (2381)
Artificial intelligence (32)
Autoimmune disease (1)
Automation (3)
Bankruptcy (19)
Best Places to Work (1105)
BIOSECURE Act (2)
Biosimilars (24)
Biotechnology (12)
Bladder cancer (11)
Brain cancer (6)
Breast cancer (24)
Cancer (288)
Cardiovascular disease (9)
Career advice (97)
Career pathing (2)
CAR-T (6)
Cell therapy (32)
Clinical research (10345)
Collaboration (145)
Compensation (25)
Complete response letters (3)
COVID-19 (332)
CRISPR (4)
C-suite (33)
Cystic fibrosis (9)
Data (307)
Depression (4)
Diabetes (23)
Diagnostics (911)
Digital health (3)
Diversity, equity & inclusion (7)
Drug discovery (24)
Drug pricing (1)
Drug shortages (3)
Duchenne muscular dystrophy (18)
Earnings (10688)
Employer branding (2)
Employer resources (9)
Events (11521)
Executive appointments (88)
FDA (2560)
Featured Employer (2)
Fibrodysplasia Ossificans Progressiva (1)
Funding (96)
Gene editing (8)
Generative AI (2)
Gene therapy (29)
GLP-1 (87)
Government (474)
Grass and pollen (2)
Guidances (4)
Healthcare (1782)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (4)
Indications (4)
Infectious disease (344)
Inflammatory bowel disease (22)
Influenza (11)
Intellectual property (23)
Interviews (7)
IPO (2198)
Job creations (449)
Job search strategy (86)
Labor market (1)
Layoffs (20)
Legal (1245)
Liver cancer (16)
Lung cancer (44)
Lymphoma (16)
Management (1)
Manufacturing (58)
MASH (10)
Medical device (1465)
Medtech (1466)
Mergers & acquisitions (4139)
Metabolic disorders (61)
Multiple sclerosis (9)
NASH (2)
Neurodegenerative disease (12)
Neuropsychiatric disorders (1)
Neuroscience (265)
NextGen: Class of 2025 (551)
Non-profit (294)
Northern California (313)
Now hiring (2)
Obesity (28)
Opinion (14)
Ovarian cancer (16)
Pain (8)
Pancreatic cancer (12)
Parkinson's disease (31)
Partnered (4)
Patents (35)
Patient recruitment (12)
Peanut (1)
People (8677)
Pharmaceutical (4)
Phase I (3070)
Phase II (4429)
Phase III (3598)
Pipeline (179)
Policy (4)
Postmarket research (339)
Preclinical (1381)
Press Release (8)
Prostate cancer (12)
Psychedelics (2)
Radiopharmaceuticals (26)
Rare diseases (46)
Real estate (1045)
Recruiting (3)
Regulatory (3703)
Reports (8)
Research institute (289)
Resumes & cover letters (5)
RSV (2)
Schizophrenia (13)
Series A (20)
Series B (8)
Service/supplier (1)
Sickle cell disease (3)
Southern California (287)
Spinal muscular atrophy (12)
Sponsored (3)
Startups (676)
Stomach cancer (1)
Supply chain (11)
Tariffs (1)
United States (2352)
Vaccines (42)
Venture capitalists (5)
Weight loss (9)
Women's health (1)
Date
Today (5)
Last 7 days (83)
Last 30 days (337)
Last 365 days (4500)
2025 (1262)
2024 (5002)
2023 (5963)
2022 (10758)
2021 (10112)
2020 (8589)
2019 (6333)
2018 (4926)
2017 (5626)
2016 (5335)
2015 (6571)
2014 (5030)
2013 (4075)
2012 (4399)
2011 (4685)
2010 (3996)
Location
Africa (133)
Alabama (2)
Arizona (18)
Arkansas (1)
Asia (22835)
Australia (2742)
California (705)
Canada (301)
China (196)
Colorado (22)
Connecticut (28)
Delaware (5)
Europe (18342)
Florida (107)
Georgia (12)
Idaho (5)
Illinois (31)
India (11)
Indiana (11)
Iowa (1)
Japan (83)
Kansas (10)
Louisiana (2)
Maine (6)
Maryland (119)
Massachusetts (450)
Michigan (7)
Minnesota (42)
Missouri (6)
Nebraska (2)
Nevada (4)
New Jersey (266)
New Mexico (1)
New York (186)
North Carolina (94)
Northern California (313)
Ohio (16)
Oklahoma (1)
Oregon (1)
Pennsylvania (95)
Puerto Rico (2)
Rhode Island (1)
South America (184)
South Carolina (1)
Southern California (287)
Tennessee (2)
Texas (55)
Utah (28)
Virginia (30)
Washington D.C. (2)
Washington State (29)
Wisconsin (7)
109,935 Results for "lg chemical ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LG Chem and Acies Bio Collaborate to Advance Sustainable Production of Chemicals
December 5, 2024
·
4 min read
Drug Development
LG Chem company and AVEO Oncology Announce LG Chem’s First Proprietary Anti-Cancer Compound enters Phase 1 Clinical Study, Dosing Initiated in the U.S.
LG Chem and AVEO Oncology, an LG Chem company, announced that it has enrolled the first patient in the United States for a Phase 1 clinical study of LB-LR1109, LG Chem’s first proprietary anti-cancer investigational drug candidate.
June 13, 2024
·
4 min read
Press Releases
AVEO Oncology, an LG Chem company, Presents Two Posters for Tivozanib at the 2025 ASCO GU Meeting
February 19, 2025
·
9 min read
Business
The Jackson Laboratory and LG AI Research partner to pioneer biomedical advancements
The Jackson Laboratory and LG AI Research signed a partnership agreement creating an alliance between JAX’s longstanding expertise in biomedical research and data analysis and LG’s AI research and product development prowess.
March 11, 2024
·
4 min read
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a contract research agreement with SEKISUI CHEMICAL CO., LTD..
January 23, 2024
·
2 min read
Drug Development
Rhythm Pharmaceuticals and LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) today announced it has entered into a global licensing agreement with LG Chem, Ltd. (“LG Chem”), a leading global company headquartered in South Korea that specializes in life sciences as one of its core businesses, for LB54640, an investigational oral small molecule melanocortin-4 receptor (MC4R) agonist now in Phase 2 clinical trials.
January 4, 2024
·
12 min read
Press Releases
New Real-World Durability of Response Data for JELMYTO Reports 68% Recurrence-Free Survival Rate (RFS) at Three Years Across a Broad Patient Population with Low-Grade Upper Tract Urothelial Cancer (LG-UTUC)
January 23, 2025
·
10 min read
Press Releases
UGN-102 Showed Promising Long-Term Results in the Phase 3 ENVISION Trial, Potentially Paving the Way for First FDA-Approved Treatment for LG-IR-NMIBC
December 6, 2024
·
7 min read
Press Releases
ENVISION Trial Results Published in the February Issue of The Journal of Urology Highlight UGN-102 Achievement of 82.3% Duration of Response at 12 Months Paving the Way for the Potential First FDA-Approved Treatment for LG-IR-NMIBC in June 2025
January 15, 2025
·
7 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
1 of 10,994
Next
